Inhibition of ribonucleotide reductase, DNA synthesis, and L1210 leukemia by guanazole.
D000225:Adenine / Q000378:metabolism; D000818:Animals; D001375:Azaguanine / Q000008:administration & dosage / Q000494:pharmacology*; D002247:Carbon Isotopes; D002294:Carcinoma, Squamous Cell / Q000378:metabolism; D046508:Culture Techniques; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D005260:Female; D005561:Formates / Q000378:metabolism; D006918:Hydroxyurea / Q000494:pharmacology; D007042:Hypoxanthines / Q000378:metabolism; D007930:Leucine / Q000378:metabolism; D007939:Leukemia L1210 / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D051379:Mice; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D002247:Carbon Isotopes; D004273:DNA, Neoplasm; D005561:Formates; D007042:Hypoxanthines; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D014316:Tritium; D010088:Oxidoreductases; D007930:Leucine; D000225:Adenine; D001375:Azaguanine; D013936:Thymidine; D014529:Uridine; D006918:Hydroxyurea